• 1
    Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997; 15: 1537.
  • 2
    Boschi-Pinto C, Stuver S, Okayama A et al . A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan. J Infect Dis 2000; 181: 3541.
  • 3
    Miyazaki K, Yamaguchi K, Tohya T, Ohba T, Takatsuki K, Okamura H. Human T-cell leukemia virus type I infection as an oncogenic and prognostic risk factor in cervical and vaginal carcinoma. Obstet Gynecol 1991; 77: 10710.
  • 4
    Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica. Lancet 1989; 2: 11847.
  • 5
    Kimura I, Tsubota T, Tada S, Sogawa J. Presence of antibodies against adult T cell leukemia antigen in the patients with chronic respiratory diseases. Acta Med Okayama 1986; 40: 2814.
  • 6
    LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990; 336: 13457.
  • 7
    Tajima K. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-Cell Malignancy Study Group. Int J Cancer 1990; 45: 23743.
  • 8
    Sun SC, Yamaoka S. Activation of NF-κB by HTLV-I and implications for cell transformation. Oncogene 2005; 24: 595264.
  • 9
    Inoue J, Gohda J, Akiyama T, Semba K. NF-κB activation in development and progression of cancer. Cancer Sci 2007; 98: 26874.
  • 10
    Mori N, Fujii M, Ikeda S et al . Constitutive activation of NF-κB in primary adult T-cell leukemia cells. Blood 1999; 93: 23608.
  • 11
    Mori N, Yamada Y, Ikeda S et al . Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 2002; 100: 182834.
  • 12
    Dewan MZ, Terashima K, Taruishi M et al . Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/γc (null) mice: suppression by an inhibitor against NF-κB. J Virol 2003; 77: 528694.
  • 13
    Ohsugi T, Horie R, Kumasaka T et al . In vivo antitumor activity of the NF-κB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia. Carcinogenesis 2005; 26: 13828.
  • 14
    Pomerantz JL, Baltimore D. Two pathways to NF-κB. Mol Cell 2002; 10: 6935.
  • 15
    Miyawaki S, Nakamura Y, Suzuka H et al . A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur J Immunol 1994; 24: 42934.
  • 16
    Shinkura R, Kitada K, Matsuda F et al . Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-κB-inducing kinase. Nat Genet 1999; 22: 747.
  • 17
    Koike R, Nishimura T, Yasumizu R et al . The splenic marginal zone is absent in alymphoplastic aly mutant mice. Eur J Immunol 1996; 26: 66975.
  • 18
    Karrer U, Althage A, Odermatt B et al . On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11−/–) mutant mice. J Exp Med 1997; 185: 215770.
  • 19
    Karrer U, Althage A, Odermatt B, Hengartner H, Zinkernagel RM. Immunodeficiency of alymphoplasia mice (aly/aly) in vivo: structural defect of secondary lymphoid organs and functional B-cell defect. Eur J Immunol 2000; 30: 2799807.
  • 20
    Hino S. Maternal transmission: diagnosis and prevention of the infected. In: TakatsukiK, HinumaY, YoshidaM, eds. Advances in Adult T-Cell Leukemia and HTLV-1 Research Japan. Tokyo: Scientific Societies Press, 1992; 16373.
  • 21
    Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang 1984; 46: 24553.
  • 22
    Etoh K, Tamiya S, Yamaguchi K et al . Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res 1997; 57: 48627.
  • 23
    Manns A, Miley WJ, Wilks RJ et al . Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J Infect Dis 1999; 180: 148793.
  • 24
    Okayama A, Stuver S, Matsuoka M et al . Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers. Int J Cancer 2004; 110: 6215.
  • 25
    Matsuzaki T, Nakagawa M, Nagai M et al . HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J Neurovirol 2001; 7: 22834.
  • 26
    Lairmore MD, Silverman L, Ratner L. Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene 2005; 24: 600515.
  • 27
    Fang J, Kushida S, Feng R et al . Transmission of human T-cell leukemia virus type 1 to mice. J Virol 1998; 72: 39527.
  • 28
    Tanaka M, Sun B, Fang J et al . Human T-cell leukemia virus type 1 (HTLV-1) infection of mice: proliferation of cell clones with integrated HTLV-1 provirus in lymphoid organs. J Virol 2001; 75: 44203.
  • 29
    Nitta T, Tanaka M, Sun B, Hanai S, Miwa M. The genetic background as a determinant of human T-cell leukemia virus type 1 proviral load. Biochem Biophys Res Commun 2003; 309: 1615.
  • 30
    Imada K, Takaori-Kondo A, Akagi T et al . Tumorigenicity of human T-cell leukemia virus type I-infected cell lines in severe combined immunodeficient mice and characterization of the cells proliferating in vivo. Blood 1995; 86: 23507.
  • 31
    Ishihara S, Tachibana N, Okayama A, Murai K, Tsuda K, Mueller N. Successful graft of HTLV-I-transformed human T-cells (MT-2) in severe combined immunodeficiency mice treated with anti-asialo GM-1 antibody. Jpn J Cancer Res 1992; 83: 3203.
  • 32
    Miyoshi I, Kubonishi I, Yoshimoto S et al . Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981; 294: 7701.
  • 33
    Fang J, Kushida S, Feng R et al . Integration of HTLV-1 provirus into mouse transforming growth factor-α gene. Biochem Biophys Res Commun 1997; 233: 7925.
  • 34
    Ibrahim F, Fiette L, Gessain A, Buisson N, De-The G, Bomford R. Infection of rats with human T-cell leukemia virus type-I: susceptibility of inbred strains, antibody response and provirus location. Int J Cancer 1994; 58: 44651.
  • 35
    Zhao TM, Hague B, Caudell DL, Simpson RM, Kindt TJ. Quantification of HTLV-I proviral load in experimentally infected rabbits. Retrovirology 2005; 2: 34.
  • 36
    Cockerell GL, De Lairmore MB, Rovnak J, Hartley TM, Miyoshi I. Persistent infection of rabbits with HTLV-I: patterns of anti-viral antibody reactivity and detection of virus by gene amplification. Int J Cancer 1990; 45: 12730.
  • 37
    Kazanji M, Ureta-Vidal A, Ozden S et al . Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responses. J Virol 2000; 74: 48607.
  • 38
    Wattel E, Vartanian JP, Pannetier C, Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 1995; 69: 28638.
  • 39
    Hanon E, Hall S, Taylor GP et al . Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000; 95: 138692.
  • 40
    Nishikawa S, Nakane A. Host resistance against Listeria monocytogenes is reciprocal during the course of infection in alymphoplastic aly mutant mice. Cell Immunol 1998; 187: 8894.
  • 41
    Czarneski J, Rassa JC, Ross SR. Mouse mammary tumor virus and the immune system. Immunol Res 2003; 27: 46980.
  • 42
    Lawn SD, Butera ST, Folks TM. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 2001; 14: 75377.
  • 43
    Gonzalez-Dunia D, Grimber G, Briand P, Brahic M, Ozden S. Tissue expression pattern directed in transgenic mice by the LTR of an HTLV-I provirus isolated from a case of tropical spastic paraparesis. Virology 1992; 187: 70510.
  • 44
    Mortreux F, Kazanji M, Gabet AS, De Thoisy B, Wattel E. Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus). J Virol 2001; 75: 10839.
  • 45
    Tanaka G, Okayama A, Watanabe T et al . The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between seroconverters and long-term carriers. J Infect Dis 2005; 191: 11407.
  • 46
    Bangham CR. The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J Gen Virol 2003; 84: 317789.
  • 47
    Furuta RA, Sugiura K, Kawakita S et al . Mouse model for the equilibration interaction between the host immune system and human T-cell leukemia virus type 1 gene expression. J Virol 2002; 76: 270313.
  • 48
    Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 1990; 64: 56827.
  • 49
    Satoh M, Toma H, Sugahara K et al . Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4+25+ HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis. Oncogene 2002; 21: 246675.
  • 50
    Yamano Y, Cohen CJ, Takenouchi N et al . Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease. J Exp Med 2004; 199: 136777.